News
FDA approves dupilumab for treatment of prurigo nodularis
Approval was based on data from two randomized, controlled trials, PRIME and PRIME2, comparing dupilumab with placebo in 311 adults with...
News
Increasing primary care doctors’ knowledge of IPF could speed up diagnoses, suggests white paper
Nonspecific symptoms of IPF may prompt primary care providers to pursue other assessment pathways.
News
Psoriasis, psoriatic arthritis insurance coverage remains restrictive
A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.
News
Corticosteroids found to curb progression in community-acquired pneumonia
Patients with CAP were less likely to progress to mechanical ventilation after corticosteroid therapy.
News
Mindfulness eases asthma burden
Asthma patients who practiced mindfulness experienced significant improvement in symptoms.
News
CRP levels could predict SSRI success
SSRIs were less effective in depressed patients with high C-reactive protein levels than in those with low levels.
News
Community-level actions could mitigate maternal mortality
National Institute for Health Care Management panelists advocate partnerships between hospitals and community centers to ease barriers to access...
News
Tralokinumab earns EU recommendation to expand age range for atopic dermatitis to include adolescents
In December 2021, tralokinumab was approved for adults with moderate to severe AD in the United States, where it is marketed as Adbry.
News
Esophageal motility issues may promote respiratory disease
High-resolution manometry showed increased dysmotility in patients with higher measures of airway reflux.
News
Inhaled vasodilator type has no impact on outcomes
Successful extubations were similar for patients on inhaled vasodilators using nitric oxide and epoprostenol in a comparison study.
News
Congenital cytomegalovirus declined in wake of COVID-19
Racial disparities remained but were lower in the pandemic period, compared with previous prepandemic studies.
News
FDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasis
Approval was based on the results of two phase 3 trials of almost 1,700 adults with moderate to severe plaque psoriasis.
News
Baseline neuromotor abnormalities persist in schizophrenia
Long-term follow-up data showed predictive value of dyskinesia and neurological soft signs for neuromotor dysfunction.
News
Isotretinoin prescribers need better education on emergency contraception
Two-thirds of providers reported receiving no education on emergency contraception, despite relevance to isotretinoin patients.
News
New study supports safety of COVID-19 boosters during pregnancy
Local and systemic reactions, such as aches and pains, from a COVID-19 booster or third dose were short-lived with no ongoing concerns in pregnant...